CR Digital Mammography System First to Have Both FDA Clearance and EUREF Certification
|
By MedImaging International staff writers Posted on 01 Feb 2012 |

Image: The DX-M CR Digital Mammography System (Photo courtesy of Agfa HealthCare).
A new computed radiography (CR) mammography digitizer that offers consistent, very high image quality is now available in the US market.
Agfa HealthCare (Mortsel, Belgium) announced that it has received FDA clearance to market its DX-M digitizer with needle-based detectors in the United States. This next-generation CR solution is the only CR digital mammography solution with both US Food and Drug Administration (FDA) clearance and EUREF (European Reference Organization for Quality Assured Breast Screening and Diagnostic Services) certification.
The DX-M with needle-based detectors provides excellent image quality with high detective quantum efficiency (DQE). With its novel five-cassette drop-and-go buffer for high throughput, it also supports a smoother workflow.
The DX-M can be used as a centralized or decentralized digitizer in the radiography department, supporting general radiography as well as digital mammography. As the reader unit can also be used with general radiography detectors, the DX-M is suitable for healthcare operations with a tight budget that wish to achieve high image quality in their X-ray imaging. The DX-M comes with Agfa HealthCare’s Musica2 advanced image processing software for consistently high image quality and enhanced details.
The phosphor needle-based DX-M is a robust system at a reduced total cost of ownership. Furthermore, this allows it to be used in more physically demanding environments, such as mobile mammography screening vans. In addition to the FDA clearance, the DX-M has also passed the rigorous physicotechnical and clinical tests for EUREF, and received EUREF certification.
“We are pleased and proud that the DX-M is the only CR digital mammography solution to have achieved both FDA clearance and EUREF certification,” commented Dirk Debusscher, vice president imaging at Agfa HealthCare. “We remain committed to offering the highest standards based on needle detectors in our CR solutions. We already have more than 3,000 digital mammography installations around the world, and more than 2,000 needle detector-based installations.”
The DX-M is a major part of Agfa HealthCare’s digital mammography solution, which also includes the Impax for Breast Imaging diagnostic workstation and Drystar imagers. By crossing imaging and healthcare information technology (IT) boundaries, it offers a fully integrated system designed for the specific needs of breast imaging departments.
Related Links:
Agfa HealthCare
Agfa HealthCare (Mortsel, Belgium) announced that it has received FDA clearance to market its DX-M digitizer with needle-based detectors in the United States. This next-generation CR solution is the only CR digital mammography solution with both US Food and Drug Administration (FDA) clearance and EUREF (European Reference Organization for Quality Assured Breast Screening and Diagnostic Services) certification.
The DX-M with needle-based detectors provides excellent image quality with high detective quantum efficiency (DQE). With its novel five-cassette drop-and-go buffer for high throughput, it also supports a smoother workflow.
The DX-M can be used as a centralized or decentralized digitizer in the radiography department, supporting general radiography as well as digital mammography. As the reader unit can also be used with general radiography detectors, the DX-M is suitable for healthcare operations with a tight budget that wish to achieve high image quality in their X-ray imaging. The DX-M comes with Agfa HealthCare’s Musica2 advanced image processing software for consistently high image quality and enhanced details.
The phosphor needle-based DX-M is a robust system at a reduced total cost of ownership. Furthermore, this allows it to be used in more physically demanding environments, such as mobile mammography screening vans. In addition to the FDA clearance, the DX-M has also passed the rigorous physicotechnical and clinical tests for EUREF, and received EUREF certification.
“We are pleased and proud that the DX-M is the only CR digital mammography solution to have achieved both FDA clearance and EUREF certification,” commented Dirk Debusscher, vice president imaging at Agfa HealthCare. “We remain committed to offering the highest standards based on needle detectors in our CR solutions. We already have more than 3,000 digital mammography installations around the world, and more than 2,000 needle detector-based installations.”
The DX-M is a major part of Agfa HealthCare’s digital mammography solution, which also includes the Impax for Breast Imaging diagnostic workstation and Drystar imagers. By crossing imaging and healthcare information technology (IT) boundaries, it offers a fully integrated system designed for the specific needs of breast imaging departments.
Related Links:
Agfa HealthCare
Latest Radiography News
- Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
- AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
- Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
- AI Detection Tool Improves Identification of Lobular Breast Cancer
- New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
- AI Boosts Breast Cancer Detection and Cuts Screening Workload
- AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
Channels
MRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channel
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read more
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read moreGeneral/Advanced Imaging
view channel
AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection
Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read moreNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







